19 May 2013
Keywords: vernalis/endo, pharma, withdraw, frova, snda, uk, drugmaker
Article | 14 April 2008
UK drugmaker Vernalis says that its US development partner Endo Pharmaceuticals has notified the Food and Drug Administration of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.